https://de.marketscreener.com/kurs/aktie/ROCHE-HOLDING-AG-9364975/news/Roche-FDA-Zulassung-fur-Venclexta-Kombinationen-bei-myeloischer-Leukamie-31562008/?utm_source=telegram&utm_medium=social&utm_campaign=share